ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Agios wins FDA nod for targeted AML drug Tibsovo
fiercepharma
July 24, 2018A year after its Celgene-partnered drug Idhifa won FDA approval to treat certain patients with relapsed/refractory acute myeloid leukemia, Agios Pharmaceuticals has scored its first FDA nod for a wholly-owned medicine, Tibsovo.
Pharma Sources Insight January 2025
